Tinzaparin vs Warfarin for Acute Venous Thromboembolism--Reply

Affiliations

¹ Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
² Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, Canada.

Comment

Alok A Khorana et al. JAMA. 2016.

. 2016 Jan 12;315(2):200-1.

doi: 10.1001/jama.2015.15070.

¹ Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
² Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, Canada.

No abstract available

Comment on

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA; CATCH Investigators. Lee AYY, et al. JAMA. 2015 Aug 18;314(7):677-686. doi: 10.1001/jama.2015.9243. JAMA. 2015. PMID: 26284719 Clinical Trial.
Tinzaparin vs Warfarin for Acute Venous Thromboembolism.
Maruyama A, Tejani AM, Perry TL. Maruyama A, et al. JAMA. 2016 Jan 12;315(2):200. doi: 10.1001/jama.2015.15067. JAMA. 2016. PMID: 26757471 No abstract available.